In comparison with the 1,2,4,6-tetrasusbtituted-piperazinone analogues A, the change of position of the basic amino acid side chain from C6 to N1 in B has led to the complete loss of PAR1 antagonist activity and tumor cell cytotoxicity. This evidence concerns the gene F2R and neoplasm.